The present Invention relates in general to the compound N - ((4aS, 6aR, 6BS, 8aR, 12aS, 14ar, 14bs) - 11 - cyano - 2,2,6a, 6B, 9.9, heptametil 12a - - 10 -, 14 - [1, 2, 3,4,4a, 5,6,6a, 6B, 7,8,8a, 9 10, 12, 14, 14a, 14b - octadecahidropiren - 4a - I (L) - 2,2 - difluoropropanamida, polymorphic forms of the same, I Two for their Preparation and use, and Pharmaceutical compositions thereof.La presente invencion se relaciona en general con el compuesto: N-((4aS,6aR,6bS,8aR, 12aS, 14aR, 14bS)-11-ciano-2,2,6a,6b,9,9, 12a-heptametil-10, 14- dioxo-1 ,2, 3,4,4a,5,6,6a,6b,7,8,8a,9, 10, 12a, 14, 14a, 14b-octadecahidropiren-4a-i l)-2,2- difluoropropanamida, formas polimorficas del mismo, metodos para su preparacion y uso, composiciones farmaceuticas del mismo.
